CBPO
China Biologic Products Holdings, Inc.
CBPO
CBPO
Delisted
CBPO was delisted on the 20th of April, 2021.
91 hedge funds and large institutions have $1.49B invested in China Biologic Products Holdings, Inc. in 2018 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 20 increasing their positions, 35 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
91
Holders Change
+5
Holders Change %
+5.81%
% of All Funds
2.09%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
21
Increased
20
Reduced
35
Closed
15
Calls
$8.25M
Puts
$8.5M
Net Calls
-$253K
Net Calls Change
+$4.64M
Top Buyers
| 1 |
YCMGA
York Capital Management Global Advisors
New York
|
+$48.3M |
| 2 |
Fidelity International
Hamilton,
Bermuda
|
+$19.8M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$10.7M |
| 4 |
PHK
Point72 Hong Kong
Hong Kong
|
+$10.3M |
| 5 |
Man Group
London,
United Kingdom
|
+$7.95M |
Top Sellers
| 1 |
VAM
Vontobel Asset Management
New York
|
-$72.9M |
| 2 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$60.3M |
| 3 |
Goldman Sachs
New York
|
-$50.9M |
| 4 |
BlackRock
New York
|
-$40.5M |
| 5 |
CGI
Comgest Global Investors
Paris,
France
|
-$39.1M |
